Welcome to Tech Beat, your daily look at the stories shaping our world.
The FDA is adding new warning labels to GLP-1 weight loss drugs, citing a potential increased risk of vision loss. These medications, already widely used for obesity and diabetes, have transformed how millions manage their health, but regulators say patients and doctors deserve a clearer picture of the risks involved.
On a different front, lab-grown meat is heading to court. A cultivated poultry company is now challenging Florida's ban on cell-cultured meat products, arguing the state is overstepping by blocking a technology that could reshape food production. The case raises real questions about who gets to decide what ends up on American dinner plates.
And in a story that blends consumer tech with everyday family life, Google has updated how personal results work on Google Home devices, allowing each household member to link their own account for a more tailored assistant experience. It sounds convenient, but it also deepens how much of your daily routine flows through a single corporate platform.
Keep surfing. Tech Beat out.
